Bulis Veronica Sanchez

VP, Corporate Controller

Bulis Veronica Sanchez has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 11, 2026.

On the most recent filing, Bulis Veronica Sanchez is listed as VP, Corporate Controller at Lyell Immunopharma, Inc. Inside the rolling window, Bulis Veronica Sanchez reported no open-market purchases and 6 open-market sales totaling $97K in LYEL. The largest disclosed transaction in the window is a sale of 1,136 LYEL shares on Dec 24, 2025, worth $44K.

Companies traded

Other insiders at LYEL

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$97K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LYELSale$9KAug 11SEC ↗
LYELSale$4KJun 15SEC ↗
LYELSale$6KFeb 11SEC ↗
LYELSale$44KJan 6SEC ↗
LYELSale$30KJan 6SEC ↗
LYELSale$4KNov 12SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Bulis Veronica Sanchez made?

Bulis Veronica Sanchez has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.

Which companies does Bulis Veronica Sanchez trade?

Bulis Veronica Sanchez has filed SEC Form 4 disclosures for 1 company, including LYEL.

When was Bulis Veronica Sanchez's most recent SEC Form 4 filing?

Bulis Veronica Sanchez's most recent SEC Form 4 filing on Tracefour is dated Aug 11, 2026.

What is Bulis Veronica Sanchez's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Bulis Veronica Sanchez is listed as VP, Corporate Controller.

What is Bulis Veronica Sanchez's total buy and sell value in the current window?

Inside the rolling retention window, Bulis Veronica Sanchez bought $0 and sold $97K based on SEC Form 4 filings.

What was Bulis Veronica Sanchez's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,136 LYEL shares on 2025-12-24, worth $44K, per SEC Form 4 filings.